Replies to post #6048 on Vericel Corp. (VCEL)

[realfast95]

HSGX

"We enrolled 82 patients in the NeoCart Phase 3 clinical trial to bring total enrollment to 196 patients at the end of 2016"

That's $7m out of VCEL's pockets.

HSGX has a math problem. They lost 30m in 2016, have 31m in cash, but say they have enough through mid-2018. That, or a bunch of people are getting fired.